Is CODX a good buy

**Co-Diagnostics (CODX) is not a good buy at this time.** Here are the key reasons: 1. **Financial Performance**: Co-Diagnostics has reported a net loss of $7.6 million and a diluted EPS of -$0.25 for the most recent quarter, indicating financial instability. 2. **Stock Price Volatility**: The stock price has experienced significant volatility, with a recent surge in price but trading below its 50-day simple moving average, which could be seen as a bearish signal. 3. **Negative Valuation Ratios**: The company's P/E(TTM) is negative at -1.06, and its P/S ratio is also negative at 6.16, which is a red flag for investors. 4. **Technical Indicators**: The technical indicators are not favorable. The stock is trading below its 5-day, 10-day, and 50-day moving averages, and the RSI, MACD, and KDJ values do not strongly suggest a buy. 5. **Market Sentiment**: There is a negative sentiment towards the stock, with a recent decline in share price and a lack of a consensus rating and price target from analysts, which could suggest a lack of confidence in the stock's future performance. In conclusion, despite the promising developments in the molecular diagnostics field, Co-Diagnostics' financial losses, stock price volatility, and negative sentiment suggest that the stock may not be a good buy at this time. Investors should exercise caution and consider these factors before making an investment decision.